Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' reply

Aliment Pharmacol Ther. 2021 Oct;54(8):1087. doi: 10.1111/apt.16579.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Crohn Disease* / drug therapy
  • Cytokines
  • Humans
  • Infliximab
  • Intestinal Mucosa
  • Wound Healing

Substances

  • Cytokines
  • Infliximab